<p>Alec Sutherland of Arizona State University in the United States will develop and test a vaccine delivery system that uses Norovirus virus-like particles (VLPs) to deliver desired antigens directly to the gut mucosa. The self-replicating RNA in the VLP will not only encode those antigens, it will also act as an adjuvant by activating several signaling pathways for an enhanced and sustained immune response.</p>


Alec Sutherland of Arizona State University in the United States will develop and test a vaccine delivery system that uses Norovirus virus-like particles (VLPs) to deliver desired antigens directly to the gut mucosa. The self-replicating RNA in the VLP will not only encode those antigens, it will also act as an adjuvant by activating several signaling pathways for an enhanced and sustained immune response.